During the past decade, Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie" #1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Granzer Regulatory Consulting & Services" with 1 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie" are "B-Cell Lymphoma" (1 trials), "Carcinoma, Pancreatic Ductal" (1 trials), "Chronic Hepatitis B" (1 trials), "Non-Hodgkin Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "Prednisone" (2 trials), "Vincristine" (2 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".